Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
P14 - Immunotherapy (Phase II/III Trials) - Clinical Trial in Progress
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 7
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P14.01 - Phase 3 Study of First-Line Pembrolizumab ± Vibostolimab (anti-TIGIT) in Patients With PD-L1‒Positive Metastatic NSCLC
00:00 - 00:00 | Presenter: Matthew D. Hellmann
- Abstract
Loading...
-
+
P50 - Novel Therapeutics and Targeted Therapies - EGFR Minor
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 8
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P50.04 - Amivantamab in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Misako Nagasaka
- Abstract
Loading... -
+
P50.09 - Characteristics and Clinical Outcomes of HER2 Mutated Non-small Cell Lung Cancer Patients Detected by NGS in Routine Clinical Practice
00:00 - 00:00 | Presenter: Yejeong Han
- Abstract
Loading...
-
+
P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 32
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P59.01 - Clinical Characteristics of Patients With MET Amplification-Positive NSCLC After EGFR-TKI Therapy
00:00 - 00:00 | Presenter: Ji Hyun Lee
- Abstract
Loading...
-
+
PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)
- Type: Plenary
- Track: N.A.
- Presentations: 11
- Moderators:David Harpole
- Coordinates: 9/09/2021, 06:30 - 08:00, Program Auditorium
-
+
PL02.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
06:30 - 06:40 | Presenter: Melissa L Johnson
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)
- Type: Plenary
- Track: N.A.
- Presentations: 11
- Moderators:David Harpole
- Coordinates: 9/09/2021, 14:30 - 16:00, Program Auditorium
-
+
PL02A.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
14:30 - 14:40 | Presenter: Melissa L Johnson
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ES04 - Antibody–Drug Conjugates: Current Status and Future Perspectives*
- Type: Education Session
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 5
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Maria Rosario García Campelo
- Coordinates: 9/10/2021, 09:00 - 09:35, Program Auditorium
-
+
ES04.04 - Antibody Drug Conjugates for Combination Therapy
09:06 - 09:08 | Presenter: Byoung Chul Cho
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA15 - Upcoming Molecular Targeted Agents for EGFR exon 20 Insertion and MET Skipping Mutation
- Type: Oral
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 6
- Moderators:Helena A Yu
- Coordinates: 9/12/2021, 18:45 - 19:45, Program Auditorium
-
+
OA15.03 - Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS
19:05 - 19:15 | Presenter: Alexander Spira
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
